4.7 Article

Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation

期刊

NATURE PROTOCOLS
卷 12, 期 9, 页码 1962-1979

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2017.078

关键词

-

资金

  1. European Community's Seventh Framework Programme through NeuroStemcellRepair [602278]
  2. European Research Council under European Union's Seventh Framework Programme/ERC [309712]
  3. Strong Research Environment at Lund University Multipark
  4. Swedish Research Council [70862601/Bagadilico, K2014-61X-20391-08-4, 2015-03444_3]
  5. Swedish Society for Medical Research
  6. UK Regenerative Medicine Platform and Innovation Fund Denmark (BrainStem)
  7. European Research Council (ERC) [309712] Funding Source: European Research Council (ERC)
  8. Lundbeck Foundation [R44-2009-3856] Funding Source: researchfish
  9. Novo Nordisk Foundation Section for Basic Stem Cell Biology [Kirkeby group NNF] Funding Source: researchfish
  10. Swedish Research Council [2015-03444] Funding Source: Swedish Research Council
  11. Vinnova [2015-03444] Funding Source: Vinnova

向作者/读者索取更多资源

Generation of precisely patterned neural cells from human pluripotent stem cells (hPSCs) is instrumental in developing disease models and stem cell therapies. Here, we provide a detailed 16-d protocol for obtaining high-purity ventral midbrain (VM) dopamine (DA) progenitors for intracerebral transplantation into animal models and for in vitro maturation into neurons. We have successfully transplanted such cells into the rat; however, in principle, the cells can be used for transplantation into any animal model, and the protocol is designed to also be compatible with clinical transplantation into humans. We show how to precisely set the balance of patterning factors to obtain specifically the caudal VM progenitors that give rise to DA-rich grafts(+) By specifying how to perform quality control (QC), troubleshooting and adaptation of the procedure, this protocol will facilitate implementation in different laboratories and with a variety of hPSC lines. To facilitate reproducibility of experiments and enable shipping of cells between centers, we present a method for cryopreservation of the progenitors for subsequent direct transplantation or terminal differentiation into DA neurons. This protocol is free of xeno-derived products and can be performed under good manufacturing practice (GMP) conditions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据